248.538.00001 Boehringer Ingelheim Investigational Site

New Haven, Connecticut

0 studies enrolling now · 1 studies all time

What they study most

Parkinson Disease

Studies at this site

• Ophthalmologic Safety Study of Pramipexole Immediate Release (IR) Versus Ropinirole in Early Parkinson's Disease (PD) Patients — Completed